Coupled with observations that loss‐of‐function mutations in the natural IL‐36 receptor antagonist promote a highly severe form of psoriasis 16, 17, 18, 19, 20, this suggests that IL‐36γ may be an important driver of the inflammation seen in this condition. The gene discussed is IL36G; the disease is psoriasis.